CASE STUDY

24x Faster Proteomics Research with PRIDE, $500K Savings

Key Highlights

  • A London-based therapeutics company faced a significant challenge in finding relevant proteomics datasets from the PRIDE repository, as only ~25% of these are completely annotated.
  • The company partnered with Elucidata to access high-quality, ML-ready proteomics data and completely annotated metadata to construct a comprehensive knowledge graph illustrating the intricate relationships and interactions between proteins in biological systems.
  • Elucidata employed a three-step approach to deliver 60 high-quality proteomics datasets, each with over 10,000 samples. These datasets aligned with their inclusion criteria, ensuring that the datasets included disease labeling and all necessary information on samples.
  • Elucidata’s Polly Verified datasets allowed them to kickstart their research in a month versus 24 months, saving them over half a million dollars.
Get your case study now
Please enter only business email ids.
Thank you for showing interest!

To know more about us, book a demo here.
Oops! Something went wrong while submitting the form.

All Case Studies

Case study: Accelerated Target ID using ML-Ready data on Polly

Data Interoperability as a Service: 6X Faster Clinico-Genomic Data Integration & Analysis with Polly

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Elucidata Cuts 95% Manual Scientist Effort in Protein Production Workflows

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Predicting Spatially Resolved Gene Expression from Histopathology Images

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

500 Hours Of Data Wrangling Saved While Ensuring Superior Data Quality

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

80% Faster Data Management & 50% Fewer Data Queries for Academic Core Facilities

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Six Months to Success: Accelerating AML Target-indication Assessment With Advanced Knowledge Graphs

Read More
Request Demo